Pivotal Therapeutics, Inc. is a pharmaceutical company, which engages in the optimization of Omega-3 therapy for cardiovascular disease and overall health. The firm’s products include Benefishial, Omazen, and Vascazen. The company was founded by Eugene G. Bortoluzzi, Rachelle MacSweeney and George Jackowski on October 1, 2010 and is headquartered in Vaughan, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company